Skip to content

PASS OCT Spinal System

by Medicrea International SA 3 variants

510(k) K150918

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK150918 Date16 Oct 2015ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
NKG
Device Class
Class II
Regulation
21 CFR Part 888.3075
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The PASS OCT Spinal System is a posterior cervical screw system (product code NKG) classified under Class II with special controls. It is designed to provide immobilization of spinal segments as an adjunct to spinal fusion, addressing acute and chronic instabilities in the craniocervical junction, cervical spine (C1–C7), and upper thoracic spine (T1–T3).

This system is intended for use in surgical settings and is supplied sterile for single-use. It is intended for immobilization of traumatic spinal fractures, dislocations, instability, or deformity. The device is authorized under FDA 510(k) clearance (K150918) and is manufactured by Medicrea International SA.

Other devices from Medicrea International SA

See all devices from Medicrea International SA →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What specific spinal regions is the PASS OCT Spinal System designed to stabilize, and how does it differ from general cervical fixation systems?

    The PASS OCT Spinal System is specifically designed to stabilize the craniocervical junction, cervical spine segments C1–C7, and the upper thoracic spine (T1–T3). Unlike general cervical fixation systems, it targets acute and chronic instabilities in these critical regions, including traumatic fractures, dislocations, instability, or deformity, making it suitable for complex cases requiring precise immobilization in these areas.

  • Is the PASS OCT Spinal System reusable, or is it intended for single-use only? How does this affect its handling and storage?

    The PASS OCT Spinal System is supplied sterile and intended for single-use only. This means it must be handled with sterile techniques during surgery and discarded after use to maintain infection control. Storage should follow sterile packaging guidelines until the device is opened for surgical use, ensuring no contamination occurs before implantation.

  • What regulatory pathway was followed for FDA clearance of the PASS OCT Spinal System, and what does this mean for clinicians or hospitals considering its use?

    The PASS OCT Spinal System received FDA clearance through a Traditional 510(k) pathway, classified under product code NKG (Class II with special controls). This means the manufacturer demonstrated that the device is substantially equivalent to a legally marketed predicate device, meeting FDA’s requirements for safety and effectiveness. Clinicians or hospitals can rely on this clearance as evidence of regulatory scrutiny before adoption.

  • How is the PASS OCT Spinal System different from other posterior cervical screw systems, particularly in terms of its intended use?

    While other posterior cervical screw systems may focus broadly on cervical spine stabilization, the PASS OCT Spinal System is explicitly designed for immobilization of the craniocervical junction, cervical spine (C1–C7), and upper thoracic spine (T1–T3). This broader scope includes addressing traumatic fractures, dislocations, instability, or deformity in these regions, making it suitable for complex cases where additional stability is required beyond standard cervical fixation.